SCHEMBL22305152

SCHEMBL22305152

CCC(=O)c1cc(Br)ccc1CC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
RAB9A P51151 1/20 0.43
HSP90AB1 P08238 1/20 0.43
CYP1A2 P05177 3/20 0.42
HPGD P15428 3/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
CES2 O00748 1/20 0.42
GALR3 O60755 1/20 0.42
ALOX15 P16050 1/20 0.42
CASP1 P29466 1/20 0.42
GAA P10253 3/20 0.42
KDM4E B2RXH2 3/20 0.40
GLA P06280 1/20 0.40
ALDH1A1 P00352 3/20 0.40
PTGDR2 Q9Y5Y4 1/20 0.39
POLB P06746 2/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14799647 0.85 HSP90AB1 (0.47) MAPTRAB9AHSP90AB1CYP1A2HPGD
SCHEMBL23243427 0.82 KDM4E (0.55) MAPTRAB9ACYP1A2HPGDCYP2C9
SCHEMBL12302945 0.82 PTGDR2 (0.51) MAPTRAB9ACYP1A2HPGDCYP2C9
SCHEMBL31125276 0.82 KDM4E (0.55) MAPTRAB9ACYP1A2HPGDCYP2C9
SCHEMBL15884062 0.81 MEN1 (0.43) MAPTRAB9AHSP90AB1CYP1A2HPGD
SCHEMBL2375910 0.81 HPGD (0.62) MAPTHSP90AB1CYP1A2HPGDCYP2C9
SCHEMBL16958719 0.80 MAPT (0.41) MAPTRAB9ACYP1A2HPGDCYP2C9
SCHEMBL182358 0.79 DGAT1 (0.46) MAPTRAB9AHSP90AB1CYP1A2HPGD
SCHEMBL1145030 0.79 KDM4E (0.61) MAPTRAB9AHSP90AB1CYP1A2HPGD
SCHEMBL30040857 0.79 KDM4E (0.61) MAPTRAB9AHSP90AB1CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020160192-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2020-08-06 WO disclosed